Atlas Trials

BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy

Clinical trial NCT01873404 · COMPLETED

Trial details

NCT number
NCT01873404
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Painful Lumbar RadiculopathySciaticaRadiculopathy
Start date
2013-06-01
Primary completion
2015-03-01
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.